Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Non-resectable Interventions: Drug: Atezolizumab; Drug: Bevacizumab; Radiation: Proton radiotherapy Sponsors: Chang Gung Memorial Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research